B

BridgeBio Oncology Therapeutics, Inc. (BBOT)

NGM – Real Time Price. Currency in USD

9.08

-0.12 (-1.30%)

Market open: Aug 12, 2026, 2:41 PM EDT

9.10

-0.10 (-1.09%)

Previous after-hours: Aug 11, 2026, 5:59 PM EDT

Get all premium features to the best stock analysis tool

Finranks

Company

About us

Contact us

[email protected]

BridgeBio Oncology Therapeutics, Inc. (BBOT)

NGM – Real Time Price. Currency in USD

9.08

-0.12 (-1.30%)

Market open: Aug 12, 2026, 2:41 PM EDT

9.10

-0.10 (-1.09%)

Previous after-hours: Aug 11, 2026, 5:59 PM EDT

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

0

Cost of goods sold

-610K

-208K

0

Gross Profit

-610K

-208K

0

Operating expenses (excl. COGS)

-145M

-81M

-42K

-4K

Operating Income

-146M

-81M

-42K

-4K

Non-operating income, total

12M

7M

0

Pretax income

-134M

-74M

-42K

-4K

Equity in earnings

0

Taxes

0

Non-controlling/minority interest

0

After tax other income/expense

0

Net income before discontinued operations

-134M

-74M

-42K

-4K

Discontinued operations

0

Net income

-134M

-74M

-42K

-4K

Dilution adjustment

0

Preferred dividends

0

Search stocks

BridgeBio Oncology Therapeutics, Inc. (BBOT)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

BridgeBio Oncology Therapeutics, Inc. (BBOT)

Income Statement (Annual)